MAIA Biotechnology MAIA Balance Sheet (2021-2026)

NYSE MAIA
$1.30 -0.03 (-2.18%)
As of: Sep 10, 2026 · 3:59 PM EDT
Reported Financials

MAIA Biotechnology Quarterly Balance Sheet

Periods 21 quarters
Latest Jun 2026

MAIA Biotechnology reported total assets of $28.24M and total liabilities of $7.57M for the quarter ended Jun 2026, up 155.7% year over year. This balance sheet covers 21 quarters of results from Jun 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
10.95M10.57M10.29M8.15M14.06M10.95M7.59M9.15M6.10M7.15M8.27M11.58M8.69M9.60M10.86M10.14M10.89M8.66M34.41M27.60M
Cash & Current Investments
10.95M10.57M10.29M8.15M14.06M10.95M7.59M9.15M6.10M7.15M8.27M11.58M8.69M9.60M10.86M10.14M10.89M8.66M34.41M27.60M
Receivables - OtherOther Receivables
0.04M0.20M0.26M0.30M0.35M0.39M0.11M0.14M0.16M0.18M0.05M0.08M0.08M0.08M0.08M0.40M0.20M0.05M
Prepaid Assets
0.05M0.26M0.46M0.55M0.40M0.24M0.41M0.27M0.27M0.26M0.50M0.47M0.92M0.82M0.78M1.04M0.90M0.64M
Current Assets
10.67M8.61M14.78M11.81M8.33M9.78M6.63M7.56M8.70M12.02M9.24M10.15M11.86M11.04M11.75M9.70M35.32M28.24M
Non-Current Assets
Other Non-Current Assets
0.65M1.15M0.00M0.21M0.74M0.49M0.37M0.00M0.01M0.00M0.00M0.00M0.00M0.00M0.03M0.00M0.01M0.00M
Non-Current Assets
0.65M1.15M0.00M0.21M0.74M0.49M0.37M0.00M0.02M0.00M0.00M0.00M0.00M0.00M0.03M0.00M0.01M0.00M
Assets
11.33M9.76M14.78M12.02M9.07M10.27M7.00M7.57M8.72M12.02M9.24M10.16M11.86M11.05M11.78M9.70M35.32M28.24M
Liabilities
Current Liabilities
Accounts Payables
0.96M1.04M1.02M1.17M1.13M1.55M1.23M1.64M1.87M1.26M1.15M1.51M1.84M1.72M3.18M2.04M2.98M2.84M
Payables
0.96M1.04M1.02M1.17M1.13M1.55M1.23M1.64M1.87M1.26M1.15M1.51M1.84M1.72M3.18M2.04M2.98M2.84M
Accumulated Expenses
1.19M2.06M1.44M2.10M2.64M1.72M2.92M3.30M3.04M2.25M2.46M2.32M3.22M3.32M6.82M3.80M3.34M3.42M
Other Accumulated Expenses
0.11M0.11M0.04M0.16M0.16M0.20M0.41M0.61M0.26M0.32M0.31M0.22M0.31M0.35M0.34M0.25M0.33M0.37M
Total Current Liabilities
2.15M3.10M2.46M3.27M3.77M3.27M4.15M4.94M4.91M3.51M3.61M3.83M5.06M5.04M9.99M5.84M6.32M6.26M
Non-Current Liabilities
Other Non-Current Liabilities
0.22M0.25M0.22M0.12M0.10M2.15M9.57M5.35M4.02M2.69M1.86M2.13M1.75M1.49M1.24M1.31M
Total Non-Current Liabilities
2.46M3.27M3.77M3.27M4.15M4.94M4.91M3.51M3.61M3.83M5.06M5.04M9.99M5.84M6.32M6.26M
Total Liabilities
-10.23M2.15M-9.01M3.10M2.67M3.51M3.99M3.39M4.25M7.09M14.48M8.86M7.62M6.52M6.92M7.17M11.74M7.33M7.56M7.57M
Shareholder's Equity
Common Equity
10.23M9.18M9.01M6.66M12.11M8.51M5.08M6.87M2.75M0.48M-5.76M3.16M1.62M3.63M4.94M3.88M0.04M2.38M27.76M20.68M
Liabilities and Shareholders Equity
11.33M9.76M14.78M12.02M9.07M10.27M7.00M7.57M8.72M12.02M9.24M10.16M11.86M11.05M11.78M9.70M35.32M28.24M
Retained Earnings
37.62M41.82M52.22M52.73M53.43M59.75M60.51M64.47M-72.05M84.11M85.29M90.90M96.73M101.00M106.07M112.05M143.80M144.65M